In this study researcher want to gain more information on the treatment effect of Low-dose Estrogen Progestin (a hormone treatment) on the health related quality of life and work productivity in patients suffering from menstrual pain. The treating doctors will ask the study participants to complete questionnaires at start of study, after 2 and 4 months (end of study). The questions will be about participant's general and mental health, concentration, behavioral and emotional changes, and work productivity and activity level. This study will be conducted in Japan and enrols about 380 female participants in the age range of 16 to 39 years.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Changes in Menstrual Distress: evaluated by modified Menstrual Distress Questionnaire (mMDQ)
Timeframe: Baseline, 60 days and 120 days
Changes in Health Related Quality of Life (HRQoL): evaluated by Short Form (36) Health Survey version 2 (SF-36v2)
Timeframe: Baseline, 60 days and 120 days
Changes in work productivity (mWPAI)
Timeframe: Baseline, 60 days and 120 days
Changes in Activity Impairment: evaluated by General Health v2.0 (WPAI-GH)
Timeframe: Baseline, 60 days and 120 days